Atriva Pharmaceutical Private Limited
About Atriva Pharmaceutical Private Limited
Data last updated:
Atriva Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC333085. Its GSTIN is 09AASCA9422F1ZC (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ravi Prakash Gupta and Shravan Kumar Mali.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at B S Mali Chawl R. No. 10 Munshi Mahal Water Tank Road Bhandup West, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.68 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹1.19 Lakh (net margin -25.5%) and EBITDA of -₹95,581 (EBITDA margin -20.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressB S Mali Chawl R. No. 10 Munshi Mahal Water Tank Road Bhandup West, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Atriva Pharmaceutical Private Limited
The main business activity of Atriva Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Atriva Pharmaceutical Private Limited FY 2023 filings available
Atriva Pharmaceutical Private Limited reported revenue of ₹4.68 Lakh (down 77% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Atriva Pharmaceutical Private Limited
Revenue fell 77% in the latest year. EBITDA fell 199% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Atriva Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹95,581 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.19 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Atriva Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -20.4% | •••• | •••• | •••• |
| Net Profit Margin | -25.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Atriva Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exclusive Trading Company Private Limited | ₹4.69 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Cadmic Pharmaceuticals Private Limited | ₹4.69 Lakh (FY 2022) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Shayonam Infinity Private Limited | ₹4.69 Lakh (FY 2019) | •••• | •••• | •••• | Nadiad, Gujarat, India | |
| Klog Exports Private Limited | ₹4.69 Lakh (FY 2020) | •••• | •••• | -8.0% | •••• | Navi Mumbai, Maharashtra, India |
| Justify Distributors Private Limited | ₹4.69 Lakh (FY 2025) | •••• | •••• | 1609.0% | •••• | Kolkata, West Bengal, India |
| Atriva Pharmaceutical Private Limited this company | ₹4.68 Lakh (FY 2023) | •••• | •••• | -77.0% | •••• | Mumbai, Maharashtra, India |
| Everx Merchandise Private Limited | ₹4.68 Lakh (FY 2020) | •••• | •••• | 282.0% | •••• | Angamaly, Kerala, India |
| Top Suppliers Private Limited | ₹4.68 Lakh (FY 2024) | •••• | •••• | 134.0% | •••• | Kolkata, West Bengal, India |
| Easymed Solutions Private Limited | ₹4.68 Lakh (FY 2022) | •••• | •••• | -36.0% | •••• | Faridabad, Haryana, India |
| Revathika Hallmarks Private Limited | ₹4.68 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Coimbatore, Tamil Nadu, India |
| Ganeshvani Distributors Private Limited | ₹4.68 Lakh (FY 2017) | •••• | •••• | 130.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Atriva Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Prakash Gupta | Director | 26 Nov 2022 | 3 Years 10 Months | Current |
| Shravan Kumar Mali | Director | 16 Nov 2019 | 6 Years 10 Months | Current |
| Shishir Shekhar Pathak | Director | 16 Nov 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Atriva Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Atriva Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Atriva Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Alka Devi ceased to be Director on 20 Jan 2023.
Credit Ratings, Litigation & Regulatory Alerts for Atriva Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Atriva Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Atriva Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA9422F1ZC | Uttar Pradesh | Active | 01 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Atriva Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atriva Pharmaceutical Private Limited
Atriva Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 November 2019 (7+ years old) and is registered under CIN U24304MH2019PTC333085.
Atriva Pharmaceutical reported revenue of ₹4.68 Lakh for FY 2023 (down 77% YoY).
Atriva Pharmaceutical has 3 current directors:
- Ravi Prakash Gupta - Director
- Shravan Kumar Mali - Director
- Shishir Shekhar Pathak - Director
Atriva Pharmaceutical reported a net loss of ₹1.19 Lakh (net margin -25.5%) and EBITDA of -₹95,581 (EBITDA margin -20.4%) for FY 2023, as per its filed financial statements.
The GSTIN of Atriva Pharmaceutical is 09AASCA9422F1ZC, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Atriva Pharmaceutical is U24304MH2019PTC333085. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atriva Pharmaceutical was incorporated on 16 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Atriva Pharmaceutical by revenue are Exclusive Trading Company Private Limited, Cadmic Pharmaceuticals Private Limited, Shayonam Infinity Private Limited, Klog Exports Private Limited, Justify Distributors Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Alka Devi ceased to be Director on 20 Jan 2023. Ravi Prakash Gupta was appointed as Director on 26 Nov 2022. Alka Devi was appointed as Director on 25 Jan 2020. Atriva Pharmaceutical has 5 board changes on record in total.
The registered office of Atriva Pharmaceutical is at B S Mali Chawl R. No. 10 Munshi Mahal Water Tank Road Bhandup West, Mumbai, Maharashtra, India – 400078.
Atriva Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.